Skip to Content

SPDR® S&P Biotech ETF XBI

Medalist Rating as of | See State Street Investment Hub

Morningstar’s Analysis XBI

Will XBI outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

SPDR ® S&P Biotech ETF’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XBI

  • Current Portfolio Date
  • Equity Holdings 134
  • Bond Holdings 0
  • Other Holdings 3
  • % Assets in Top 10 Holdings 13.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
1.49
84,251,105
Healthcare
1.37
77,154,254
Healthcare
1.36
76,600,338
Healthcare
1.35
76,284,394
Healthcare
1.34
75,957,343
Healthcare
1.34
75,607,582
Healthcare
1.33
75,305,588
Healthcare
1.33
75,123,031
Healthcare
1.32
74,661,006
Healthcare
1.31
73,721,131
Healthcare